Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSL#3 for SBP Prevention in Cirrhosis
NCT01701297Phase 2Terminated
- Sponsor
- Nottingham University Hospitals
- Start
- Feb 2012
- Primary completion
- Oct 2014
- Modality
- Multi-strain Products
- Countries
- 1
01
Overview
A Phase 2 trial of VSL#3 in spontaneous bacterial peritonitis (SBP), sponsored by Nottingham University Hospitals. Started Feb 2012; status: terminated.
02
Drugs
VSL#3
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT01701297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01701297.